ABSTRACT PlasmoDB
INTRODUCTION
Plasmodium spp. are obligate intracellular protozoan parasites of humans and animals, and are the causative agents of malaria. Transmission of these parasites to humans occurs via the Anopheles mosquito vector and the geographic distribution of endemic regions puts almost half of the world's population at risk to contracting malaria. This disease is a major source of morbidity and mortality worldwide, which results in 300-500 million clinical cases and 1-2 million deaths annually (1, 2) . While several species of Plasmodium cause disease in humans (including P. vivax, P. malariae, P. ovale and P. knowlesi), P. falciparum is by far the deadliest (1, 3) . The life cycle of the Plasmodium parasite takes it through multiple cell types (in the vertebrate host and arthropod vector) during which the parasite undergoes multiple developmental changes (both sexual and asexual). The different life-cycle stages are marked by specific genomic, transcriptomic, proteomic and metabolomic states. Understanding how these changes are triggered and orchestrated requires mechanisms to view and interrogate genomic and functional genomic data in a powerful and intuitive manner. Over the past 10 years, PlasmoDB has evolved into a venue that integrates such data and allows the user to perform complex queries tailored to their specific needs and interests.
UPDATED DATA CONTENT
The data available in PlasmoDB has expanded to include genomic and functional data from eight Plasmodium species and is summarized in Table 1 (4) . The current release (PlasmoDB 5.5) contains fully sequenced and annotated genomes of P. falciparum, P. vivax, P. yoelii, P. berghei, P. chabaudi and P. knowlesi. Importantly, PlasmoDB 5.5 contains results of annotation efforts from multiple sources including the recent systematic effort to update the P. falciparum genome that is an ongoing project started at a workshop in late 2007 co-organized by the Wellcome Trust Sanger Institute (WTSI) and EuPathDB (formerly ApiDB) teams. Reannotation data have been released in incremental steps (snapshots) in order to provide timely information to users of PlasmoDB and to solicit user comments regarding the reannotations.
Transcript expression data [microarray, expressed sequence tags (ESTs) and serial analysis of gene expression (SAGE)] available through PlasmoDB has expanded dramatically over the past few releases to include microarray data from multiple life-cycle stages, gene knock-out mutants of P. falciparum and P. berghei (5-12) and multiple stages of P. yoelii (mosquito, erythrocytic and liver stages) (13) . Also included are EST data from over 130 libraries (P. falciparum, P. vivax, P. berghei and P. yoelii) (14, 15) [dbEST (http://www.ncbi.nlm.nih.gov/dbEST/)] and SAGE data (P. falciparum only) (16) (17) (18) . Protein expression evidence includes data from various lifecycle stages (P. falciparum, P. berghei and P. yoelii) (11, 13, (19) (20) (21) ; Leiden Malaria Group, unpublished data).
Population biology evidence (P. falciparum only) includes mapping of microsatellite data (22) onto the genome (available as a genome browser track), single nucleotide polymorphism (SNP) data from resequencing efforts of more than 20 P. falciparum strains (P. reichenowi is included as an out-group for comparison purposes) and data from nearly 100 P. falciparum isolates (23) (24) (25) . OrthoMCL analyses provide ortholog determinations between the different species facilitating discovery of shared genes between lineages (26) . Protein function assignments are aided by a number of additional functional data types available through PlasmoDB 5.5 including Identify genes targeted to the host cell.
Apicoplast targeting P. falciparum
Identify genes targeted to the apicoplast. evidence of protein-protein interaction (yeast two hybrid and predicted interactome) (27, 28) , Genome Ontology (GO) (29) and InterPro domain (30) annotations for P. falciparum, P. vivax, P. berghei, P. yoelii, P. knowlesi and P. chabaudi, Enzyme Commission (EC) number (29) annotation for P. falciparum, P. yoelii and P. knowlesi (31) and metabolic pathway assignments for P. falciparum (31) . In addition, subcellular localization of proteins is available through signal peptide (32) and transmembrane domain predictions (33) for P. falciparum, P. vivax, P. berghei, P. yoelii, P. knowlesi and P. chabaudi, and parasite-specific predictions (P. falciparum only) for apicoplast localization (34) and export to the host cell (35) (36) (37) .
HOW TO USE PLASMODB
A visitor to PlasmoDB can use the database in two general ways: (i) To retrieve all available information associated with a particular gene of interest using a search for an exact gene ID, gene name or gene product name.
(ii) To ask single questions (Table 1) and/or conduct a series of searches followed by refining the results by combining them or subtracting them from one another. Starting with the PlasmoDB home page ( Figure 1A ), a user can perform a quick search by entering an identifier or test term, or select a specific query from a number of dropdown menus (data not shown). Alternatively, queries may be accessed by visiting the 'Queries and Tools' section of PlasmoDB ( Figure 1A ), which includes a grid displaying all available queries/searches. By using the queries and tools, a user can interrogate data in PlasmoDB-the third column of Table 1 includes example data-specific questions that are available. When conducting queries with the purpose of combining results it may be useful to visualize the searches in a workflow environment where nodes are connected using different criteria ('and', 'or', 'not') ( Figure 1B) . In PlasmoDB this would be accomplished by performing a number of queries and subsequently combining the results in the 'query history' section ( Figure 1C , middle screen shot). For example, one may be interested in identifying a short list of possible vaccine candidates. One possible way of accomplishing this would be by identifying all proteins predicted to be exported to the host cell in P. falciparum. There are three exported protein datasets in PlasmoDB and a union ('or' function) of all three results retrieves 405 genes ( Figure 1B, steps 1 and 2 ). To restrict this list further, intersecting ('and' function) these results with genes that have no orthologs in mammals reduces the results to 321 genes ( Figure 1B, Step 3) . Next a user may further prune this list by intersecting the results with other queries, such as genes that are nonpolymorphic between a chloroquine sensitive (3D7) and resistant strain (Dd2). This cuts the number of candidates to 32 genes ( Figure 1B, Step 4 and Figure 1C , right screen shot). Alternatively, one may be interested in the genes that have protein expression evidence in a particular stage in the parasite's life cycle (the results of an intersection with genes that have proteomic evidence in gametocyte yields 27 genes). Finally, examination of the list reveals several genes encoding for rifins (a family of clonally variant proteins expressed on the surface of infected red blood cells) (38) , and a user may wish to investigate genes other than rifins-this can be accomplished by excluding ('not' operation) results of a keyword query using the term 'rifin' ( Figure 1B, Step 5 and Figure 1C , left most panel). A user may examine the specific gene pages for more gene-specific details, download results with their associated data or log in (if they have not done so already) to ensure that their search strategy is saved for future examination.
FUTURE DIRECTIONS
It is expected that PlasmoDB will continue its data content and tool expansion as user needs require. We anticipate the incorporation of multiple new data sets including microarray, proteomic and specific parasite isolate data. Additionally, over the next few years we look forward to incorporating sequence data from a dramatically expanded Plasmodium spp. sequencing effort (http:// www.genome.gov/26525388). In the coming year, we will also release a new user interface that will include a workflow-based search strategy page, similar to what is shown in Figure 1B , which we anticipate will provide a more biologically intuitive and dynamic experience for scientists accessing PlasmoDB and other EuPathDB sites.
